A Comparison of Lipids and apoB in Asian Indians and Americans

A Comparison of Lipids and apoB in Asian Indians and Americans

Background and aims:Apolipoprotein B (apoB) integrates and extends the information from the conventional measures of atherogenic cholesterol and triglyceride. To illustrate how apoB could simplify and improve the management of dyslipoproteinemia, we compared conventional lipid markers and apoB in a...

Full description

Bibliographic Details
Main Authors:	Kavita Singh, George Thanassoulis, Line Dufresne, Albert Nguyen, Ruby Gupta, KM Venkat Narayan, Nikhil Tandon, Allan Sniderman, Dorairaj Prabhakaran
Format:	Article
Language:	English
Published:	Ubiquity Press 2021-01-01
Series:	Global Heart
Subjects:	dyslipidemia apolipoprotein b india united states atherosclerotic vascular disease
Online Access:	https://globalheartjournal.com/articles/882

Similar Items

Novel protein-truncating variant in the APOB gene may protect from coronary artery disease and adverse cardiovascular events
by: Castagna, A., et al.
Published: (2022)

Looking Beyond LDL-Cholesterol - A Study on Extended Lipid Profile in Indian Patients with Acute Coronary Syndrome
by: Naveen Kumar, et al.
Published: (2019-11-01)

Increased VLDL-apoB and IDL-apoB production rates in nonlipodystrophic HIV-infected patients on a protease inhibitor-containing regimen
by: Jean Michel Petit, et al.
Published: (2003-09-01)

Potent reduction of plasma lipoprotein (a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis
by: Michael B. Boffa, et al.
Published: (2019-12-01)

Egyptian practical guidance in lipid management 2020
by: Hesham Salah El Din Taha, et al.
Published: (2021-02-01)

Association between apolipoprotein B/A1 ratio and coronary plaque vulnerability in patients with atherosclerotic cardiovascular disease: an intravascular optical coherence tomography study
by: Fuxue Deng, et al.
Published: (2021-09-01)

Development of a sensitive ELISA to quantify apolipoprotein CIII in nonhuman primate serum
by: Yuxin Wang, et al.
Published: (2011-06-01)

Recent Advances in Primary and Secondary Prevention of Atherosclerotic Stroke
by: Georgios Tsivgoulis, et al.
Published: (2018-05-01)

Overexpression ofapoC-III produces lesser hypertriglyceridemia in apoB-48-only gene-targeted micethan in apoB-100-only mice
by: Karin Conde-Knape, et al.
Published: (2004-12-01)

The bridging function of hepatic lipase clears plasma cholesterol in LDL receptor-deficient “apoB-48-only” and “apoB-100-only” mice
by: Helén L. Dichek, et al.
Published: (2004-03-01)

Dimyristoylphosphotidylcholine induces conformational changes in apoB that lowers lipoprotein(a)
by: Yan-Ting Wang, et al.
Published: (2009-05-01)

APOLIPOPROTEIN A1 GENE AND ITS ROLE IN DYSLIPIDEMIA DEVELOPMENT ACROSS ETHNIC GROUPS OF PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION
by: T. A. Bairova, et al.
Published: (2012-12-01)

Cardiometabolic health among United States firefighters by age
by: Steven M. Moffatt, et al.
Published: (2021-09-01)

Lipid transfer proteins in the assembly of apoB-containing lipoproteins
by: Alaa Sirwi, et al.
Published: (2018-01-01)

Oxidative events cause degradation of apoB-100 but not of apo[a] and facilitate enzymatic cleavage of both proteins
by: Celina Edelstein, et al.
Published: (2001-10-01)

Antisense inhibition of apoB synthesis with mipomersen reduces plasma apoC-III and apoC-III-containing lipoproteins
by: Jeremy D. Furtado, et al.
Published: (2012-04-01)

Lipid Profile in Women with Polycystic Ovary Syndrome
by: Amini Leila, et al.
Published: (2014-10-01)

Lack of association between PstI polymorphism in the 3\' flanking region of the apolipoprotein AI gene and serum lipids levels in an Iranian population
by: Abbas Pakdel, et al.
Published: (2017-06-01)

<b> Influence of apolipoprotein-E gene on lipid profile, physical activity and body fat relationship</b>
by: Thales Boaventura Rachid Nascimento, et al.
Published: (2012-03-01)

Apolipoproteins: Good Markers for Cardiovacular Risk in Patients with Chronic Kidney Disease and Dyslipidemia
by: Tudor Mirela - Nicoleta, et al.
Published: (2014-09-01)

Abnormal in vivo metabolism of apoB-containing lipoproteins in human apoE deficiency
by: Katsunori Ikewaki, et al.
Published: (2004-07-01)

Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding
by: Allan D. Sniderman, et al.
Published: (2018-01-01)

Inhibitory effect of the combination therapy of simvastatin and pinocembrin on atherosclerosis in apoE-deficient mice
by: Sang Hui, et al.
Published: (2012-12-01)

Improvement initiative in LDL-C management in Saudi Arabia: A call to action
by: Mirvat Alasnag, et al.
Published: (2020-12-01)

Down-regulated of SREBP-1 in circulating leukocyte is a risk factor for atherosclerosis: a case control study
by: Chunyan Peng, et al.
Published: (2019-10-01)

Preventive cardiology as a dedicated clinical service: The past, the present, and the (Magnificent) future
by: Michael D. Shapiro, et al.
Published: (2020-03-01)

Genetic determinants of lipid aberrations in patents with essential hypertension
by: V. V. Buriak, et al.
Published: (2020-04-01)

The Acute Regulation of Intestinal Chylomicron Secretion by Glucagon-like Peptides
by: Hsieh, Joanne
Published: (2012)

The Acute Regulation of Intestinal Chylomicron Secretion by Glucagon-like Peptides
by: Hsieh, Joanne
Published: (2012)

Effects of APOE, APOB and LDLR variants on serum lipids and lack of association with xanthelasma in individuals from Southeastern Brazil
by: Marcelo A. Nakazone, et al.
Published: (2009-01-01)

Low density lipoprotein delays clearance of triglyceride-rich lipoprotein by human subcutaneous adipose tissue
by: Simon Bissonnette, et al.
Published: (2013-05-01)

The APOB gene polymorphism in the pathogenesis of gallstone disease in pre- and postmenopausal women
by: Karolina Rudzińska, et al.
Published: (2015-02-01)

A monoclonal antibody to assess oxidized cholesteryl esters associated with apoAI and apoB-100 lipoproteins in human plasma1[S]
by: Ayelet Gonen, et al.
Published: (2019-02-01)

Metabolism of apoB lipoproteins of intestinal and hepatic origin during constant feeding of small amounts of fat
by: Chunyu Zheng, et al.
Published: (2006-08-01)

Ersonified diagnostic and correction dyslipidemia approach by profiling of apolipoproteins
by: M. A. Kachkovsky, et al.
Published: (2020-12-01)

Apolipoprotein E polymorphism in Brazilian dyslipidemic individuals: Ouro Preto study
by: A. Mendes-Lana, et al.
Published: (2007-01-01)

Novel fatty acyl apoE mimetic peptides have increased potency to reduce plasma cholesterol in mice and macaques[S]
by: G.M. Anantharamaiah, et al.
Published: (2018-11-01)

Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology
by: Børge G. Nordestgaard, et al.
Published: (2016-11-01)

Lipoprotein apheresis to treat elevated lipoprotein (a)1
by: Elisa Waldmann, et al.
Published: (2016-10-01)

Sources and properties of triglyceride-rich lipoproteins containing apoB-48 and apoB-100 in postprandial blood plasma of patients with primary combined hyperlipidemia
by: J. Kovar, et al.
Published: (2002-07-01)